MUSCULOSKELETAL TRANSPLANT FOUNDATION

MTF Biologics is a not-for-profit tissue bank and allograft processor founded nearly 40 years ago and originally established by orthopedic surgeons. The company processes and distributes human allograft tissues for clinical applications across orthopedic surgery, plastic and reconstructive surgery, soft tissue reconstruction, and advanced wound repair. Core product lines include bone allografts, cartilage allografts, meniscal allografts, fresh osteochondral allografts, soft tissue grafts, and dermal allografts for burn and chronic wound management (diabetic foot ulcers, venous leg ulcers, sacral ulcers, tunneling wounds). MTF Biologics employs aseptic processing without terminal radiation or harsh chemicals, claiming to be the only U.S. tissue bank using 100% aseptic processing methodology. This approach preserves natural tissue structure and biological properties. The company operates a fully-digital graft matching platform allowing surgeons to upload imaging, receive anatomical matching confirmation, and streamline surgical planning. MTF Biologics maintains an international division with a global network of partners, agents, and distributors. The company has distributed over 12 million grafts to date without documented cases of viral disease transmission. Regulatory compliance and donor screening exceed industry standards. The organization provides continuing medical education (CME) to healthcare professionals. As a not-for-profit entity, MTF Biologics focuses on patient outcomes, research advancement, and grantmaking to support tissue transplantation science.